Joshua Benjamin Bergmann
CIK: 0002131863
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GYRE
GYRE THERAPEUTICS, INC.
Officer
Discretionary Trading P&L
Holdings
About Bergmann Joshua Benjamin
Bergmann Joshua Benjamin (SEC CIK 0002131863) files insider reports with the SEC as GC and Corporate Secretary of GYRE THERAPEUTICS, INC. (GYRE).
Signal8 holds 2 ownership filings by Bergmann Joshua Benjamin (1 Form 3, 1 Form 4), filed between May 7, 2026 and Jun 10, 2026. Those filings report 1 transaction, the latest on Jun 8, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bergmann Joshua Benjamin's filings is in SAN DIEGO, CA.
Recent filings by Bergmann Joshua Benjamin
- Jun 8, 2026: Grant or award of GYRE derivative securities (Form 4, code A).
Other insiders filing for GYRE THERAPEUTICS, INC. (GYRE)
- Weston Claire, Director
- Kirkby Maxwell, Director
- Ye Weiguo, Chief Operating Officer
- Luo Ying, Chief Executive Officer
- Zhang Ping, Director
- Wang Jialiang (NMN), EVP, General Manager